Gines Diego Miralles - Mar 14, 2025 Form 3 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Role
Director
Signature
/s/ Peter Slover, Attorney-in-Fact
Stock symbol
CTNM
Transactions as of
Mar 14, 2025
Transactions value $
$0
Form type
3
Date filed
3/17/2025, 04:10 PM
Previous filing
Jul 18, 2024
Next filing
Jun 26, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CTNM Stock Option (right to buy) Mar 14, 2025 Class A Common Stock 5K $17.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted under the Issuer's 2024 Equity Incentive Plan. The option is fully vested.

Remarks:

Exhibit 24 - Power of Attorney